Page last updated: 2024-10-27

foscarnet and Hepatic Failure

foscarnet has been researched along with Hepatic Failure in 3 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avery, RK1
Bolwell, BJ1
Yen-Lieberman, B1
Lurain, N1
Waldman, WJ1
Longworth, DL1
Taege, AJ1
Mossad, SB1
Kohn, D1
Long, JR1
Curtis, J1
Kalaycio, M1
Pohlman, B1
Williams, JW1
Rodriguez, J1
Casper, K1
Smallwood, G1
Stieber, A1
Fasola, C1
Lehneman, J1
Heffron, T1
Dumortier, J1
Durupt, S1
Chevallier, M1
Trépo, C1
Zoulim, F1

Other Studies

3 other studies available for foscarnet and Hepatic Failure

ArticleYear
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
    Bone marrow transplantation, 2004, Volume: 34, Issue:12

    Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combi

2004
Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:10

    Topics: Antibodies, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug R

2007
[Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir].
    Gastroenterologie clinique et biologique, 1997, Volume: 21, Issue:12

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids;

1997